3 completed. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Abnormalities, Drug-Induced: new trials by email Literature Review of Abnormalities, Drug-Induced trials Research Report on Abnormalities, Drug-Induced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening Progesterone, Ibutilide, Testosterone - Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Completed | Indiana University | 73 | 2021-09-02 | 2026-10-20 |
| Reducing the Risk of Drug-Induced QT Interval Lengthening in Women Progesterone, Ibutilide - Long QT Syndrome, Abnormalities, Drug-Induced | Phase 4 | Completed | Indiana University | 27 | 2019-03-26 | 2025-07-01 |
| Electronic Notification of Teratogenic Risks Clinical decision support, stream-lined clinical alert - Teratogens, Abnormalities, Drug-Induced | Not applicable | Completed | University of Pittsburgh | 2593 | 2008-10-01 | 2011-05-12 |
Long QT Syndrome (2)
Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Arrhythmias, Cardiac (2) · Cardiac Conduction System Disease (2) · Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Heart Defects, Congenital (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Progesterone (2) · ibutilide (2) · Testosterone (1)
Indiana University (2) · University of Pittsburgh (1)
United States (3)
James E Tisdale, PharmD (2) · Eleanor B Schwarz, MD, MS (1)
R01HL153114 (1)